Literature DB >> 3041515

Diagnosis of nosocomial pneumonia.

D M Bamberger1.   

Abstract

Nosocomial pneumonia occurs in 0.6% of hospitalized patients. The usual causative agents are gram-negative bacilli, Staphylococcus aureus, Streptococcus pneumoniae, and anaerobic bacteria. In immunocompromised hosts, the differential diagnosis also includes fungi, mycobacteria, viruses, Nocardia, and Pneumocystis carinii. Important risk factors for the development of nosocomial pneumonia include prolonged mechanical ventilation, thoracic or upper abdominal surgery, altered mental status, underlying immunosuppression, chronic obstructive pulmonary disease, and the use of antacids or histamine type 2 blockers. Colonization of the oropharynx and tracheal secretions with gram-negative aerobic bacteria is common in hospitalized patients with or without pneumonia. The diagnosis of nosocomial pneumonia is usually based on the clinical features of dyspnea, cough, fever, purulent sputum production, new pulmonary infiltrates, hypoxemia, and leukocytosis. However, the clinician must recognize that the presence of these features is neither sensitive nor specific in the diagnosis of nosocomial pneumonia. Microbiologic diagnosis is also difficult because blood cultures are usually negative, and cultures of tracheal secretions, although usually sensitive, are not specific. Invasive procedures may prove useful, but most have yet to be studied in large groups of patients with nosocomial pneumonia.

Entities:  

Mesh:

Year:  1988        PMID: 3041515

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  1 in total

1.  Arctigenin alleviates myocardial infarction injury through inhibition of the NFAT5-related inflammatory phenotype of cardiac macrophages/monocytes in mice.

Authors:  Shi-Hao Ni; Shu-Ning Sun; Zheng Zhou; Yue Li; Yu-Sheng Huang; Huan Li; Jia-Jia Wang; Wei Xiao; Shao-Xiang Xian; Zhong-Qi Yang; Ling-Jun Wang; Lu Lu
Journal:  Lab Invest       Date:  2019-12-02       Impact factor: 5.662

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.